However, magnetic resonance (MR) is a well-known non-invasive medical tool, its modalities are not routinely used in the clinical oncologic practice. The multi-modal comprehensive set of computer-evaluated quantitative MR parameters of the brain tissue in patients with suspected intracranial tumors could provide more recent, more accurate and wealthier information about the tumor tissue. Most helpful are in this regard, proton and phosphorus magnetic resonance spectroscopy (1H and 31P MRS), relaxometry of T2 values, dynamic-contrast enhancement MRI (DCE MRI), and diffusion-weighted MRI (DWI). Their measurement techniques, evaluating methods as well as clustering multi-parametric analysis could be key instruments in diagnostic of intracranial tumors.